0001144204-17-062249.txt : 20171204 0001144204-17-062249.hdr.sgml : 20171204 20171204171741 ACCESSION NUMBER: 0001144204-17-062249 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171204 FILED AS OF DATE: 20171204 DATE AS OF CHANGE: 20171204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bayley Matthew D CENTRAL INDEX KEY: 0001723040 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35112 FILM NUMBER: 171237890 MAIL ADDRESS: STREET 1: C/O AEVI GENOMIC MEDICINE, INC. STREET 2: 435 DEVON PARK DR., SUITE 715 CITY: WAYNE STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aevi Genomic Medicine, Inc. CENTRAL INDEX KEY: 0001138776 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980217544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 435 DEVON PARK DRIVE, STREET 2: SUITE 715 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 610-254-4201 MAIL ADDRESS: STREET 1: 435 DEVON PARK DRIVE, STREET 2: SUITE 715 CITY: WAYNE STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: MEDGENICS, INC. DATE OF NAME CHANGE: 20090623 FORMER COMPANY: FORMER CONFORMED NAME: MEDGENICS INC DATE OF NAME CHANGE: 20010419 3 1 tv480735_3.xml OWNERSHIP DOCUMENT X0206 3 2017-12-04 1 0001138776 Aevi Genomic Medicine, Inc. GNMX 0001723040 Bayley Matthew D C/O AEVI GENOMIC MEDICINE, INC. 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 1 0 0 0 Exhibit 24 - Power of Attorney /s/ Brian D. Piper as Attorney-in Fact for Matthew D. Bayley 2017-12-04 EX-24 2 tv480735_ex24.htm EXHIBIT 24

Exhibit 24

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of Brian Piper and Bill Noss with full power to act singly as the undersigned’s true and lawful attorneys-in-fact, with full power of substitution, to:

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director and/or beneficial owner of Aevi Genomic Medicine, Inc. (the “Company”), Form ID Application, Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID Application, Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to the attorneys-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact or their substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

This power of attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 14^th day of November, 2017.

	By:	/s/ Matthew D. Bayley
	Name:	Matthew D. Bayley
	Title:	Director